{
  "type": "hyp",
  "text": "In vitro and in vivo studies with losartan small interfering RNA specific for calcineurin and FK506 demonstrated that Ang II-mediated sFlt-1 release was via Ang II type 1 receptor activation and calcineurin signalling respectively.\n",
  "self": {
    "NER": {
      "answers": [
        "vivo",
        "losartan",
        "RNA",
        "FK506",
        "Ang II",
        "Ang II",
        "1"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "In vitro and what type of studies did losartan small interfering RNA specific",
          "What drug was used to study sFlt-1 release?",
          "What is losartan used for?",
          "What is the Ang II type 1 receptor activation that causes sFlt-1",
          "What type of receptor activation is involved in sFlt-1 release?",
          "What type of receptor activation is involved in sFlt-1 release?",
          "What type of receptor activation did studies with losartan show?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "vivo studies",
        "calcineurin",
        "Ang II-mediated sFlt-1 release",
        "Ang II type 1 receptor activation",
        "calcineurin"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "In vitro and what type of studies have shown that Ang II-mediated sF",
          "What is the Ang II type 1 receptor activation?",
          "What was demonstrated by studies with losartan small interfering RNA specific for calc",
          "What did studies with losartan show was responsible for sFlt-1 release?",
          "What is the Ang II type 1 receptor activation?"
        ]
      }
    }
  },
  "asked": {
    "In vitro and what type of studies did losartan small interfering RNA specific": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "in vivo",
        "answerability": 0.978827178478241,
        "ground_truth": {
          "vivo": {
            "bertscore": 0.8416681289672852,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What drug was used to study sFlt-1 release?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "losartan",
        "answerability": 0.8896404504776001,
        "ground_truth": {
          "losartan": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is losartan used for?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.45913803577423096,
        "ground_truth": {
          "RNA": {
            "bertscore": 0.6859530806541443,
            "f1": 0
          }
        }
      }
    },
    "What is the Ang II type 1 receptor activation that causes sFlt-1": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "calcineurin signalling",
        "answerability": 0.8277459144592285,
        "ground_truth": {
          "FK506": {
            "bertscore": 0.6852054595947266,
            "f1": 0
          }
        }
      }
    },
    "What type of receptor activation is involved in sFlt-1 release?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Ang II type 1",
        "answerability": 0.9897404909133911,
        "ground_truth": {
          "Ang II": {
            "bertscore": 0.8576678037643433,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What type of receptor activation did studies with losartan show?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Ang II type 1",
        "answerability": 0.9687142372131348,
        "ground_truth": {
          "1": {
            "bertscore": 0.7605939507484436,
            "f1": 0.4
          }
        }
      }
    },
    "In vitro and what type of studies demonstrated that Ang II-mediated sFl": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "in vivo",
        "answerability": 0.9400150775909424,
        "ground_truth": {
          "vivo studies": {
            "bertscore": 0.7040117383003235,
            "f1": 0.5
          }
        }
      }
    },
    "What is the Ang II type 1 receptor activation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "calcineurin signalling",
        "answerability": 0.7979768514633179,
        "ground_truth": {
          "calcineurin": {
            "bertscore": 0.8737058639526367,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What was demonstrated by studies with losartan small interfering RNA specific for calc": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Ang II-mediated sFlt-1 release",
        "answerability": 0.6549527645111084,
        "ground_truth": {
          "Ang II-mediated sFlt-1 release": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What did studies with losartan show was responsible for sFlt-1 release?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Ang II type 1 receptor activation",
        "answerability": 0.9924057126045227,
        "ground_truth": {
          "Ang II type 1 receptor activation": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    }
  }
}